Psychosis Flashcards

1
Q
  • positive symptoms: hallucinations, delusions, disorganized or incoherent thought
  • negative: flat affect, social isolation, alogia poverty of speech, avolition, anhedonia, cognitive deficits
  • neurodevelopmental, 50% heritability, abberant dopaminergic/glutamatergic/serotongergic activity
A

schizophrenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

positive symptoms arise from hyperactivity of one or more of the CNS systems, possibly mesolimbic and mesocortical

A

dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

_______ can cause psychosis and make schizophrenics worse

A

amphetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

these receptors mediate hallucinogenic effects

A

serotonin (5-HT2a,2c)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

phenylcyclidine and ketamine produce effects that resemble aspects of schizophrenia and exacerbate symptoms in schizo, related to this NT

A

glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

all antipsychotics are _______ receptor antagonists

A

D2 dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • sedation, decreased agitation
  • positive symptoms improve over weeks to months (problem w/ dopamine hypothesis)
  • negative symptoms may be improved by newer drugs
  • antiemetic due to blockade of dopamine receptors in chemoreceptor trigger zone, not useful for motion sickness
A

pharmacological effects of antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • extrapyramidal effects (EPS)
  • dystonia (1-5 days), unknown painful muscle cramps
  • akathisia (5-60 days), unknown motor restlessness
  • parkinsonian symptoms (5-30 days), tremor rigidity and bradykinesia due to blockade of striatal dopamine receptors, can be treated w/ anticholinergics
A

early antipsychotic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • increased prolactin release
  • orthostatic hypotension
  • weight gain
  • metabolic syndrome, diabetes (treat w/ olanzepine)
  • decreases seizure threshold
  • neuroleptic malignant syndrome (treat w/ dantrolene)
A

side effects of antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • tardive dyskinesia (abnormal movements and facial disfugurement), frequently irreversible, maybe due to long term dopaminergic receptor blockade
  • perioral tremor (rabbit syndrome)
  • agranulocytosis with clozapine
A

long term antipsychotic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  • effective against positive but not negative symptoms
  • produce EPS and tardive dyskinesia
  • all D2 antagonists
A

typical antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

chlorpromazine, fluphenazine, and thioridazine are in what drug class?

A

phenothiazines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

historically most widely prescribed antipsychotic, relatively more selective for dopamine receptors than most of typical antipsychotics, highest incidence of EPS

A

haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  • no EPS or tardive dyskinesia

- antagonist at 5HT2 receptors

A

atypical antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • activity at broad spectrum of receptors
  • no EPS or tardive dyskinesia
  • some effect on negative symptoms
  • agranulocytosis in 3%
  • approved only for treatment resistant patients
A

clozapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  • significant 5-HT2 antagonist activity
  • generally improved side effect profile, fewer extraneous receptor interactions
  • less EPS
A

newer antipsychotics (risperidone, lurasidone)

17
Q
  • newer antipsychotics
  • high incidence of weight gain and metabolic syndrome
  • may improve negative symptoms
A

olanzapine, quetiapine

18
Q
  • newer antipsychotic

- D2, 5-HT2a, 5-HT1d antagonist

A

ziprasidone

19
Q
  • newer antipsychotic
  • D2, 5HT1a partial agonist
  • 5HT2a antagonist
  • partial agonism at D2 receptors may allow for sufficient stimulation to prevent EPS, while preventing overstimulation
A

aripiprazole

20
Q
  • management of agitation and psychotic symptoms in acute mania and bipolar
  • delirum, demantia
  • alcoholic hallucinations (NOT during withdrawal, increased risk of seizures)
  • bipolar maintenance
  • dopamine agonist induced psychotic symptoms
  • tourettes, huntington’s
  • refractory depression
A

other uses of antipsychotics